BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 19280776)

  • 21. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 22. The answerable question and a hierarchy of evidence.
    Hamilton J
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
    [No Abstract]   [Full Text] [Related]  

  • 23. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
    Preston RJ; Kollins SH; Swanson JM; Greenhill LL; Wigal T; Elliott GR; Vitiello B
    Cancer Lett; 2005 Dec; 230(2):292-4. PubMed ID: 16019134
    [No Abstract]   [Full Text] [Related]  

  • 24. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Question 2 Should a child with ADHD and epilepsy be given ritalin?
    Boyes C
    Arch Dis Child; 2010 Sep; 95(9):759-61. PubMed ID: 20716679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Infantile psychosis secondary to methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T; Reed MD; Findling RL
    Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 29. [Utilization of methylphenidate(Ritalin) in France].
    Frances C; Hoizey G; Millart H; Trenque T
    Therapie; 2002; 57(2):189-93. PubMed ID: 12185970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attention deficit hyperactivity syndrome (ADHS) in Germany].
    Schlander M
    Krankenpfl J; 2004; 42(5-6):152. PubMed ID: 15527216
    [No Abstract]   [Full Text] [Related]  

  • 31. Improving decision making in the treatment of ADHD.
    Vitiello B
    Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 34. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on investigation of Ritalin conspiracy.
    J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):10. PubMed ID: 11197990
    [No Abstract]   [Full Text] [Related]  

  • 36. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 37. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 38. Attention-deficit/hyperactivity disorder: a personal perspective.
    Ginsberg ML
    Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
    Zetterström R
    Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.